Novartis AG: Key Facts
- FY2025 revenue: $54.532B.
- FY2025 net income: $13.967B.
- Employees: 75,267 full-time equivalent employees as of December 31, 2025.
- Leadership: CEO Vasant Narasimhan.
- Status: public, NYSE: NVS.
- Headquarters: Basel, Switzerland.
How Novartis Makes Money
Novartis makes money by discovering, developing, manufacturing, and commercializing patented medicines across cardiovascular, renal and metabolic, immunology, neuroscience, and oncology markets.
Why Novartis Matters
Novartis's advantage is a focused patented-medicine portfolio, global commercial reach, scale in clinical development, and specialty platforms such as radioligand therapy.
Biggest Risk
The biggest risk is patent expiry pressure, price regulation, trial failure, and competition from generics, biosimilars, and rival branded therapies.
